ResMed Financials
| RME Stock | EUR 236.00 0.50 0.21% |
ResMed |
Understanding current and past ResMed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ResMed's financial statements are interrelated, with each one affecting the others. For example, an increase in ResMed's assets may result in an increase in income on the income statement.
ResMed Stock Summary
ResMed competes with BW OFFSHORE, SOLSTAD OFFSHORE, BROADWIND ENRGY, Broadcom, and Texas Roadhouse. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED INC is traded on Frankfurt Stock Exchange in Germany.| Foreign Associate | Canada |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US7611521078 |
| Business Address | 9001 Spectrum Center |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.resmed.com |
| Phone | 858 836 5000 |
| Currency | EUR - Euro |
You should never invest in ResMed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ResMed Stock, because this is throwing your money away. Analyzing the key information contained in ResMed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ResMed Key Financial Ratios
There are many critical financial ratios that ResMed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ResMed Inc reports annually and quarterly.| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Target Price | 261.67 | |||
| Beta | 0.47 | |||
| Z Score | 22.8 |
ResMed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ResMed's current stock value. Our valuation model uses many indicators to compare ResMed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ResMed competition to find correlations between indicators driving ResMed's intrinsic value. More Info.ResMed Inc is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ResMed Inc is roughly 2.04 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ResMed's earnings, one of the primary drivers of an investment's value.ResMed Inc Systematic Risk
ResMed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ResMed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on ResMed Inc correlated with the market. If Beta is less than 0 ResMed generally moves in the opposite direction as compared to the market. If ResMed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ResMed Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ResMed is generally in the same direction as the market. If Beta > 1 ResMed moves generally in the same direction as, but more than the movement of the benchmark.
ResMed November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ResMed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ResMed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of ResMed Inc based on widely used predictive technical indicators. In general, we focus on analyzing ResMed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ResMed's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.03 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 11.82 | |||
| Value At Risk | (2.50) | |||
| Potential Upside | 1.79 |
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |